Gene · 4929
Papers4,115
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 4,115
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Optimized reporters for multiplexed detection of transcription factor activity. | bioRxiv | 2024 | 39091757 | PubTator, text mining | PubMed |
| Structural Optimization of Oxaprozin for Selective Inverse Nurr1 Agonism. | J Med Chem | 2024 | 39081058 | PubTator, text mining | PubMed |
| The roles of orphan nuclear receptor 4 group A1 and A2 in fibrosis. | Int Immunopharmacol | 2024 | 39029235 | PubTator, text mining | PubMed |
| iPSC-Derived Astrocytes and Neurons Replicate Brain Gene Expression, Epigenetic, Cell Morphology and Connectivity Alterations Found in Autism. | Cells | 2024 | 38994948 | PubTator, text mining | PubMed |
| Potential effects of Resatorvid and alpha lipoic acid on gentamicin-induced nephrotoxicity in rats. | Pharmacol Res Perspect | 2024 | 38992963 | PubTator, text mining | PubMed |
| The complex association between the immune system and the skeletal system in osteoporosis: A study of single-cell RNA sequencing. | Int Immunopharmacol | 2024 | 38976947 | PubTator, text mining | PubMed |
| A pan-cancer analysis unveiling the function of NR4A family genes in tumor immune microenvironment, prognosis, and drug response. | Genes Genomics | 2024 | 38976216 | PubTator, text mining | PubMed |
| Development of Nurr1 agonists from amodiaquine by scaffold hopping and fragment growing. | Commun Chem | 2024 | 38951694 | PubTator, text mining | PubMed |
| Author Correction: CB2 receptor activation inhibits the phagocytic function of microglia through activating ERK/AKT-Nurr1 signal pathways. | Acta Pharmacol Sin | 2024 | 38890527 | PubTator, text mining | PubMed |
| The Nurr1 ligand indole acetic acid hydrazide loaded onto ZnFe2O4 nanoparticles suppresses proinflammatory gene expressions in SimA9 microglial cells. | Sci Rep | 2024 | 38886466 | PubTator, text mining | PubMed |
| Endocrine toxicity of atrazine and its underlying mechanisms. | Toxicology | 2024 | 38815618 | PubTator, text mining | PubMed |
| NR4A2 as a Novel Target Gene for Developmental and Epileptic Encephalopathy: A Systematic Review of Related Disorders and Therapeutic Strategies. | Int J Mol Sci | 2024 | 38791237 | PubTator, text mining | PubMed |
| Nurr1 overexpression in the primary motor cortex alleviates motor dysfunction induced by intracerebral hemorrhage in the striatum in mice. | Neurotherapeutics | 2024 | 38704311 | PubTator, text mining | PubMed |
| Corrigendum to "Nurr1: A vital participant in the TLR4-NF-κB signal pathway stimulated by a-synuclein in BV-2 cells" [Neuropharmacol. (2019) 144 388-399] doi:10.1016/j.neuropharm.2018.04.008. | Neuropharmacology | 2024 | 38688816 | PubTator, text mining | PubMed |
| PON3::LCN1 and HTN3::MSANTD3 Gene Fusions With NR4A3/NR4A2 Expression in Salivary Acinic Cell Carcinoma. | Am J Surg Pathol | 2024 | 38682454 | PubTator, text mining | PubMed |
| Lineage Reprogramming: Genetic, Chemical, and Physical Cues for Cell Fate Conversion with a Focus on Neuronal Direct Reprogramming and Pluripotency Reprogramming. | Cells | 2024 | 38667322 | PubTator, text mining | PubMed |
| Differentiation of neural stem cells from human olfactory mucosa into dopaminergic neuron-like cells. | IUBMB Life | 2024 | 38662920 | PubTator, text mining | PubMed |
| Deciphering the heterogeneity dominated by tumor-associated macrophages for survival prognostication and prediction of immunotherapy response in lung adenocarcinoma. | Sci Rep | 2024 | 38653742 | PubTator, text mining | PubMed |
| ASCL1-mediated direct reprogramming: converting ventral midbrain astrocytes into dopaminergic neurons for Parkinson's disease therapy. | BMB Rep | 2024 | 38649147 | PubTator, text mining | PubMed |
| Oxidized low-density lipoproteins impair the pro-atherosclerotic effect of granulocyte-macrophage-colony-stimulating factor-producing T helper cells on macrophages. | Scand J Immunol | 2024 | 38605563 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4929/papers?page=10